Published in Langenbecks Arch Surg on March 15, 2008
Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB (Oxford) (2012) 1.01
Liver resections in metastatic gastric cancer. HPB (Oxford) (2010) 1.00
Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg (2012) 0.87
Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England. Gastric Cancer (2016) 0.86
Surgical treatment of liver metastases of gastric cancer: state of the art. World J Surg Oncol (2012) 0.85
Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies. Medicine (Baltimore) (2015) 0.83
Surgery for liver metastasis from gastric cancer. Transl Gastroenterol Hepatol (2016) 0.83
Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis. World J Gastroenterol (2015) 0.82
Hepatic metastases from gastric cancer: A surgical perspective. World J Gastroenterol (2015) 0.80
Isolation and characterization of circulating tumor cells from human gastric cancer patients. J Cancer Res Clin Oncol (2014) 0.79
Isolated ovarian metastasis of gastric cancer: Krukenberg tumor. Contemp Oncol (Pozn) (2013) 0.77
Clinical modalities for management of gastric cancer hepatic metastasis. Int J Clin Exp Med (2015) 0.75
Hepatectomy for liver metastases from gastric cancer: a systematic review. BMC Surg (2017) 0.75
Comparison of Therapeutic Efficacy between Gastrectomy with Transarterial Chemoembolization Plus Systemic Chemotherapy and Systemic Chemotherapy Alone in Gastric Cancer with Synchronous Liver Metastasis. Chin Med J (Engl) (2015) 0.75
Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study. PLoS One (2017) 0.75
Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63
Gastric adenocarcinoma: review and considerations for future directions. Ann Surg (2005) 3.83
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg (1998) 1.79
Hepatic resection for metastatic tumors from gastric cancer. Ann Surg (2002) 1.79
Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol (1999) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery (2003) 1.67
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg (1994) 1.32
A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol (2001) 1.27
Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol (1997) 1.24
Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer (2000) 1.23
Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg (2001) 1.13
Evaluation of treatment for gastric cancer with liver metastasis. Cancer (1985) 1.12
Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors. Surgery (1993) 1.10
Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg (1995) 1.02
Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery (1995) 1.00
Prognostic studies on gastric cancer with concomitant liver metastases. Hepatogastroenterology (2001) 0.90
Prognostic factors and survival of patients aged less than 45 years with colorectal cancer. Br J Surg (1994) 0.86
Management of gastric cancer patients with synchronous hepatic metastasis: a retrospective study. Hepatogastroenterology (1996) 0.86
Evaluation of treatment for synchronous hepatic metastases from gastric cancer with special reference to long-term survivors. Surg Today (2002) 0.83
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer (2011) 2.42
Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg (2006) 1.88
Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer (2010) 1.81
Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial. Ann Surg Oncol (2013) 1.66
Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway. Mol Cancer (2010) 1.64
Indication and procedure for treatment of hepatolithiasis. Arch Surg (2002) 1.53
Gram-positive cocci are associated with the formation of completely pure cholesterol stones. Am J Gastroenterol (2002) 1.52
Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand. J Biol Chem (2006) 1.49
Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. Genome Res (2011) 1.47
Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg (2006) 1.42
RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. Neoplasia (2012) 1.36
TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med (2010) 1.29
Reducing residual and recurrent stones by hepatectomy for hepatolithiasis. J Gastrointest Surg (2007) 1.21
Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg (2006) 1.20
Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 1.18
Hemangiopericytoma in the sacrococcygeal space: a case report. J Med Case Rep (2010) 1.16
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2012) 1.16
A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy. Am J Surg (2010) 1.15
Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep (2011) 1.13
The REM sleep behavior disorder screening questionnaire: validation study of a Japanese version. Sleep Med (2009) 1.11
The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy. World J Surg (2005) 1.09
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. Cancer Sci (2009) 1.08
So-called carcinosarcoma of the gallbladder; spindle cell carcinoma of the gallbladder: report of a case. Surg Today (2002) 1.08
Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas (2013) 1.07
Long-term prognosis after treatment of patients with choledocholithiasis. Ann Surg (2003) 1.05
Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma. Cancer Sci (2012) 1.05
How do we predict the clinically relevant pancreatic fistula after pancreaticoduodenectomy?--an analysis in 244 consecutive patients. World J Surg (2009) 1.04
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04
The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Ann Surg (2012) 1.03
Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg (2009) 1.02
Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer. Int J Cancer (2011) 1.02
Relation between morningness-eveningness score and depressive symptoms among patients with delayed sleep phase syndrome. Sleep Med (2011) 1.02
Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma. J Hepatobiliary Pancreat Surg (2009) 1.01
Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center. Arch Surg (2009) 1.00
A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age. J Hepatobiliary Pancreat Surg (2009) 0.99
The role of cognitive-motor function in precipitation and inhibition of epileptic seizures. Epilepsia (2005) 0.99
Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nat Commun (2013) 0.98
Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98
Postoperative evaluation of C-tube drainage after hepatectomy. Hepatogastroenterology (2003) 0.98
Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. J Bone Miner Res (2011) 0.97
Usefulness of a large automated health records database in pharmacoepidemiology. Environ Health Prev Med (2010) 0.97
Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients. J Gastroenterol (2014) 0.97
Combined use of contrast-enhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases. World J Surg (2010) 0.97
Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transport. J Bone Miner Res (2012) 0.95
Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice. PLoS One (2013) 0.95
Clinicopathological features of malignant intraductal papillary mucinous tumors of the pancreas: the differential diagnosis from benign entities. Arch Surg (2004) 0.95
Clinical significance of drainage tube insertion in laparoscopic cholecystectomy: a prospective randomized controlled trial. J Hepatobiliary Pancreat Surg (2007) 0.94
Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery (2012) 0.94
Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Arch Surg (2009) 0.93
SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. Exp Mol Pathol (2010) 0.93
Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2014) 0.93
Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today (2010) 0.93
Reconstruction of an infected recurrent ventral hernia after a mesh repair using a pedicled tensor fascia lata flap: report of two cases. Surg Today (2009) 0.93
Long-term comorbidity of diabetes mellitus is a risk factor for perineal wound complications after an abdominoperineal resection. Langenbecks Arch Surg (2008) 0.93
Increased risk of acute pancreatitis in patients with type 2 diabetes: an observational study using a Japanese hospital database. PLoS One (2012) 0.92
Complications with reconstruction procedures in pylorus-preserving pancreaticoduodenectomy. World J Surg (2005) 0.92
Laparoscopic surgery for rectal cancer: review of published literature 2000-2009. Surg Today (2011) 0.92
Molecular mechanism of the life and death of the osteoclast. Ann N Y Acad Sci (2006) 0.92
Clinicopathological characteristics of remnant gastric cancer after a distal gastrectomy. J Gastrointest Surg (2010) 0.92
Pivotal role of Bcl-2 family proteins in the regulation of chondrocyte apoptosis. J Biol Chem (2008) 0.92
Timing of laparoscopic cholecystectomy for acute cholecystitis with cholecystolithiasis. Hepatogastroenterology (2004) 0.92
Phase I/II clinical trial using HLA-A24-restricted peptide vaccine derived from KIF20A for patients with advanced pancreatic cancer. J Transl Med (2013) 0.91
The antiapoptotic protein Bcl-xL negatively regulates the bone-resorbing activity of osteoclasts in mice. J Clin Invest (2009) 0.91
Differences in findings of nocturnal polysomnography and multiple sleep latency test between narcolepsy and idiopathic hypersomnia. Clin Neurophysiol (2011) 0.91
A central pancreatectomy for benign or low-grade malignant neoplasms. J Gastrointest Surg (2009) 0.90
An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg (2007) 0.90